Abiopharma

🔍 Romano Steven J. (Executive)

Company: Silence Therapeutics plc (SLN)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 300,000 shares of Employee Share Option (Right to Buy) at $2.05 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 300,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: One fourth (1/4th) of the shares subject to the option shall vest on January 2, 2027 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.